
Apple
has started rolling out the watchOS 5.1.2 update for its Apple Watch, and this
is an important, given it comes with the much talked about ECG feature for the
Series 4 version. The
company announced its latest version of the Watch along with the iPhone XS
series back in September, which promised a new
electrocardiography (ECG) app and an app to detect irregular heart
rhythm apps.
Right
now Apple only has FDA clearance for its ECG and irregular heart rhythm app,
which is why this is coming to the United States first. If the feature has to
launch in India, it will be need regulatory approval here as well.
Apple
says the ECG app will be “capable of generating an ECG similar to a single-lead
electrocardiogram.” In a regular hospital, an ECG usually relies on 12-lead to
conduct the test, so Apple’s solution is fairly simple.
Apple’s
ECG feature works with the user placing their finger on the digital crown of
Series 4 watch and after 30 seconds, it detects the heart rhythm. The digital
crown has electrodes built-in for this.
The
irregular heart rhythm app will be able to detect most cases of arrhythmia,
where the heart rhythms are too fast or too slow. There’s a crystal electrode
at the back of the watch to read the heart’s electrical impulses from the
wearer’s wrist.
However,
Apple Watch Series 4 is not a replacement for hospital tests for an ECG or a
doctor’s prescribed test. Even if the watch does detect a problem with the
heart rhythm, the final call have to be taken by a doctor after regular tests
have been carried.
Based
on the FDA clearance, Apple Watch Series 4 is a Class II device and needs
“special labelling” and has to meet “mandatory performance standards.” The FDA
clearance for Apple Watch Series 4 also notes that ECG feature is not meant for
those under 22 years of age and for anyone with known arrhythmia or other
heart-related problems.
The
data showed by the Apple Watch is only meant for informational use, and the
final diagnosis needs to come from a doctor.
No comments:
Post a Comment